1. Antiviral Activity of N
- Author
-
Andrei E, Siniavin, Mikhail S, Novikov, Vladimir A, Gushchin, Alexander A, Terechov, Igor A, Ivanov, Maria P, Paramonova, Elena S, Gureeva, Leonid I, Russu, Nadezhda A, Kuznetsova, Elena V, Shidlovskaya, Sergei I, Luyksaar, Daria V, Vasina, Sergei A, Zolotov, Nailya A, Zigangirova, Denis Y, Logunov, and Alexander L, Gintsburg
- Subjects
COVID-19 Vaccines ,SARS-CoV-2 ,Humans ,Uracil ,Antiviral Agents ,COVID-19 Drug Treatment - Abstract
Despite the widespread use of the COVID-19 vaccines, the search for effective antiviral drugs for the treatment of patients infected with SARS-CoV-2 is still relevant. Genetic variability leads to the continued circulation of new variants of concern (VOC). There is a significant decrease in the effectiveness of antibody-based therapy, which raises concerns about the development of new antiviral drugs with a high spectrum of activity against VOCs. We synthesized new analogs of uracil derivatives where uracil was substituted at the N
- Published
- 2022